News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shire Pharmaceuticals Group plc (SHPGY) Initiates Two Adult ADHD Outreach Programs



8/17/2009 8:32:47 AM

PHILADELPHIA, Aug. 17 /PRNewswire-FirstCall/ -- Shire plc, the global specialty biopharmaceutical company, today announced two initiatives reinforcing their commitment to the care of adults with Attention-Deficit/Hyperactivity Disorder (ADHD), a psychiatric behavioral disorder that affects an estimated 10 million adults across the country.* The first initiative, "RoADHD Trip," a multi-city self screening tour, will visit eight cities across the country in an effort to raise awareness that ADHD in adults is a real and treatable medical disorder. The second initiative, ADHD Clinical Education (ACE) Program, includes a field-based team of experienced psychiatric nurses who will provide in-office education to physicians and their staff on ADHD in adults.

Read at PR Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES